• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿巴卡韦诱导的药物初治个体的 T 细胞反应具有同种免疫反应的特征。

Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses.

机构信息

Clinic for Rheumatology and Clinical Immunology/Allergology, University Hospital of Bern, Bern, Switzerland.

Regional Blood Transfusion Service of the Swiss Red Cross, Bern, Switzerland.

出版信息

PLoS One. 2014 Apr 21;9(4):e95339. doi: 10.1371/journal.pone.0095339. eCollection 2014.

DOI:10.1371/journal.pone.0095339
PMID:24751900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3994040/
Abstract

Abacavir hypersensitivity is a severe hypersensitivity reaction which occurs exclusively in carriers of the HLA-B57∶01 allele. In vitro culture of PBMC with abacavir results in the outgrowth of abacavir-reacting CD8+ T cells, which release IFNγ and are cytotoxic. How this immune response is induced and what is recognized by these T cells is still a matter of debate. We analyzed the conditions required to develop an abacavir-dependent T cell response in vitro. The abacavir reactivity was independent of co-stimulatory signals, as neither DC maturation nor release of inflammatory cytokines were observed upon abacavir exposure. Abacavir induced T cells arose in the absence of professional APC and stemmed from naïve and memory compartments. These features are reminiscent of allo-reactivity. Screening for allo-reactivity revealed that about 5% of generated T cell clones (n = 136) from three donors were allo-reactive exclusively to the related HLA-B58∶01. The addition of peptides which can bind to the HLA-B57∶01-abacavir complex and to HLA-B58∶01 during the induction phase increased the proportion of HLA-B58∶01 allo-reactive T cell clones from 5% to 42%. In conclusion, abacavir can alter the HLA-B57∶01-peptide complex in a way that mimics an allo-allele ('altered self-allele') and create the potential for robust T cell responses.

摘要

阿巴卡韦超敏反应是一种严重的超敏反应,仅发生在 HLA-B57∶01 等位基因携带者中。用阿巴卡韦体外培养 PBMC 会导致阿巴卡韦反应性 CD8+T 细胞的扩增,这些细胞释放 IFNγ并具有细胞毒性。这种免疫反应是如何诱导的,这些 T 细胞识别什么,仍然是一个争论的问题。我们分析了在体外产生阿巴卡韦依赖性 T 细胞反应所需的条件。阿巴卡韦的反应性不依赖于共刺激信号,因为在阿巴卡韦暴露时没有观察到 DC 成熟或炎症细胞因子的释放。阿巴卡韦诱导的 T 细胞在没有专业 APC 的情况下出现,源自幼稚和记忆区室。这些特征使人联想到同种异体反应性。同种异体反应性筛选显示,来自三个供体的 136 个生成的 T 细胞克隆(n=136)中,约有 5%仅对相关 HLA-B58∶01 表现出同种异体反应性。在诱导阶段添加可结合 HLA-B57∶01-阿巴卡韦复合物和 HLA-B58∶01 的肽,可将 HLA-B58∶01 同种异体反应性 T 细胞克隆的比例从 5%增加到 42%。总之,阿巴卡韦可以改变 HLA-B57∶01-肽复合物,使其模拟同种异体等位基因(“改变的自身等位基因”),并产生强大的 T 细胞反应的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/58192105aae9/pone.0095339.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/7705f643fc90/pone.0095339.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/5f3f12d1c32f/pone.0095339.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/56dc67f734e0/pone.0095339.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/64e3692b3415/pone.0095339.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/6d04cdcffa00/pone.0095339.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/5167a46d9b25/pone.0095339.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/58192105aae9/pone.0095339.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/7705f643fc90/pone.0095339.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/5f3f12d1c32f/pone.0095339.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/56dc67f734e0/pone.0095339.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/64e3692b3415/pone.0095339.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/6d04cdcffa00/pone.0095339.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/5167a46d9b25/pone.0095339.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cba8/3994040/58192105aae9/pone.0095339.g007.jpg

相似文献

1
Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses.阿巴卡韦诱导的药物初治个体的 T 细胞反应具有同种免疫反应的特征。
PLoS One. 2014 Apr 21;9(4):e95339. doi: 10.1371/journal.pone.0095339. eCollection 2014.
2
T-cells from HLA-B*57:01+ human subjects are activated with abacavir through two independent pathways and induce cell death by multiple mechanisms.来自HLA-B*57:01+人类受试者的T细胞通过两条独立途径被阿巴卡韦激活,并通过多种机制诱导细胞死亡。
Chem Res Toxicol. 2013 May 20;26(5):759-66. doi: 10.1021/tx400060p. Epub 2013 Apr 12.
3
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.药物修饰的 HLA-肽库引发的免疫自身反应性。
Nature. 2012 Jun 28;486(7404):554-8. doi: 10.1038/nature11147.
4
Comparison of abacavir-specific effector and proliferating functions of CD8 T cells in abacavir-treated HIV-1 patients.比较阿巴卡韦治疗的 HIV-1 患者中 CD8 T 细胞的阿巴卡韦特异性效应和增殖功能。
Microbiol Immunol. 2020 Mar;64(3):210-218. doi: 10.1111/1348-0421.12769. Epub 2020 Jan 31.
5
Abacavir-reactive memory T cells are present in drug naïve individuals.阿巴卡韦反应性记忆T细胞存在于未接受过药物治疗的个体中。
PLoS One. 2015 Feb 12;10(2):e0117160. doi: 10.1371/journal.pone.0117160. eCollection 2015.
6
Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B*57 : 01-restricted CD8+ T-cell activation.迈向去个性化阿巴卡韦疗法:化学修饰消除HLA-B*57:01限制性CD8+ T细胞活化。
AIDS. 2015 Nov 28;29(18):2385-95. doi: 10.1097/QAD.0000000000000867.
7
Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity.阿巴卡韦诱导新型自身肽加载到 HLA-B*57:01:一个与 HLA 相关药物过敏反应的自身免疫模型。
AIDS. 2012 Jul 17;26(11):F21-9. doi: 10.1097/QAD.0b013e328355fe8f.
8
Structural Elements Recognized by Abacavir-Induced T Cells.阿巴卡韦诱导的T细胞识别的结构元件。
Int J Mol Sci. 2017 Jul 7;18(7):1464. doi: 10.3390/ijms18071464.
9
The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice.程序性死亡蛋白1(PD1)抑制通路和成熟树突状细胞在人白细胞抗原转基因PD1基因敲除小鼠的阿巴卡韦超敏反应中起作用。
Toxicology. 2021 Nov;463:152971. doi: 10.1016/j.tox.2021.152971. Epub 2021 Oct 1.
10
Drug-induced alloreactivity: A new paradigm for allorecognition.药物诱导的同种异体反应:同种异体识别的新模式。
Am J Transplant. 2019 Sep;19(9):2606-2613. doi: 10.1111/ajt.15470. Epub 2019 Jun 17.

引用本文的文献

1
Molecular insights into the HLA-B35 molecules' classification associated with HIV control.关于与HIV控制相关的HLA - B35分子分类的分子见解。
Immunol Cell Biol. 2024 Jan;102(1):34-45. doi: 10.1111/imcb.12698. Epub 2023 Oct 9.
2
Fatal toxic epidermal necrolysis associated with sinomenine in a patient with primary membranous nephropathy.原发性膜性肾病患者中与青藤碱相关的致死性中毒性表皮坏死松解症
Clin Nephrol Case Stud. 2023 Aug 7;11:126-131. doi: 10.5414/CNCS111159. eCollection 2023.
3
Risk Assessment in Drug Hypersensitivity: Detecting Small Molecules Which Outsmart the Immune System.

本文引用的文献

1
HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin.HLA 单倍型决定了半抗原或 p-i T 细胞对氟氯西林的反应性。
J Immunol. 2013 May 15;190(10):4956-64. doi: 10.4049/jimmunol.1202949. Epub 2013 Apr 17.
2
Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA.人类白细胞抗原(HLA)相关药物过敏反应:药物与 HLA 结合的后果。
Allergy. 2012 Nov;67(11):1338-46. doi: 10.1111/all.12008. Epub 2012 Sep 3.
3
HLA and pharmacogenetics of drug hypersensitivity.人类白细胞抗原和药物过敏的药物遗传学。
药物超敏反应中的风险评估:检测那些能骗过免疫系统的小分子。
Front Allergy. 2022 Feb 22;3:827893. doi: 10.3389/falgy.2022.827893. eCollection 2022.
4
A Comprehensive Review of and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine.药物性皮疹伴嗜酸性粒细胞增多和系统症状(DRESS)及严重皮肤不良反应的综合综述:对临床药物基因组学和精准医学的启示
Pharmaceuticals (Basel). 2021 Oct 25;14(11):1077. doi: 10.3390/ph14111077.
5
Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity.免疫耐受系统的调节决定了对 HLA 介导的阿巴卡韦诱导的皮肤毒性的易感性。
Commun Biol. 2021 Sep 28;4(1):1137. doi: 10.1038/s42003-021-02657-2.
6
Drug and Chemical Allergy: A Role for a Specific Naive T-Cell Repertoire?药物和化学物质过敏:特定初始T细胞库的作用?
Front Immunol. 2021 Jun 29;12:653102. doi: 10.3389/fimmu.2021.653102. eCollection 2021.
7
Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire.阿巴卡韦诱导的主要组织相容性复合物 I 肽库重塑动力学。
Front Immunol. 2021 May 19;12:672737. doi: 10.3389/fimmu.2021.672737. eCollection 2021.
8
The important role of non-covalent drug-protein interactions in drug hypersensitivity reactions.非共价药物-蛋白相互作用在药物过敏反应中的重要作用。
Allergy. 2022 Feb;77(2):404-415. doi: 10.1111/all.14962. Epub 2021 Jun 14.
9
Massive clonal expansion of polycytotoxic skin and blood CD8 T cells in patients with toxic epidermal necrolysis.中毒性表皮坏死松解症患者皮肤和血液 CD8 T 细胞的多克隆毒性扩增。
Sci Adv. 2021 Mar 19;7(12). doi: 10.1126/sciadv.abe0013. Print 2021 Mar.
10
Drug Reaction with Eosinophilia and Systemic Symptoms: A Complex Interplay between Drug, T Cells, and Herpesviridae.药物反应伴嗜酸性粒细胞增多和全身症状:药物、T 细胞和疱疹病毒科之间的复杂相互作用。
Int J Mol Sci. 2021 Jan 23;22(3):1127. doi: 10.3390/ijms22031127.
Pharmacogenomics. 2012 Aug;13(11):1285-306. doi: 10.2217/pgs.12.108.
4
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.药物修饰的 HLA-肽库引发的免疫自身反应性。
Nature. 2012 Jun 28;486(7404):554-8. doi: 10.1038/nature11147.
5
Graft-versus-host disease or toxic epidermal necrolysis: diagnostic dilemma after liver transplantation.移植物抗宿主病或中毒性表皮坏死松解症:肝移植后的诊断困境
Transpl Infect Dis. 2012 Aug;14(4):422-6. doi: 10.1111/j.1399-3062.2012.00746.x. Epub 2012 Jun 1.
6
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.药物过敏反应是由 MHC 呈递的自身肽库改变引起的。
Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9959-64. doi: 10.1073/pnas.1207934109. Epub 2012 May 29.
7
Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity.阿巴卡韦诱导新型自身肽加载到 HLA-B*57:01:一个与 HLA 相关药物过敏反应的自身免疫模型。
AIDS. 2012 Jul 17;26(11):F21-9. doi: 10.1097/QAD.0b013e328355fe8f.
8
Avidity determines T-cell reactivity in abacavir hypersensitivity.亲合力决定阿巴卡韦超敏反应中 T 细胞的反应性。
Eur J Immunol. 2012 Jul;42(7):1706-16. doi: 10.1002/eji.201142159. Epub 2012 Jun 14.
9
Early immune events in the induction of allergic contact dermatitis.过敏性接触性皮炎诱导中的早期免疫事件。
Nat Rev Immunol. 2012 Jan 13;12(2):114-24. doi: 10.1038/nri3150.
10
Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany.变应性接触性皮炎:流行病学、分子机制、体外方法和监管方面。在德国 BfR 举行的国际研讨会上汇集的现有知识。
Cell Mol Life Sci. 2012 Mar;69(5):763-81. doi: 10.1007/s00018-011-0846-8. Epub 2011 Oct 14.